DCTH logo Delcath Systems : DCTH

DCTH

Stock Data

$10.80

Change up

$0.42 (4.05%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

MEDICAL DEVICES

Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company is headquartered in New York, New York.

All Delcath Systems Articles

12 Articles

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.